| Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial SB Hanauer, BG Feagan, GR Lichtenstein, LF Mayer, S Schreiber, ... The Lancet 359 (9317), 1541-1549, 2002 | 5090 | 2002 |
| Infliximab for induction and maintenance therapy for ulcerative colitis P Rutgeerts, WJ Sandborn, BG Feagan, W Reinisch, A Olson, J Johanns, ... New England Journal of Medicine 353 (23), 2462-2476, 2005 | 4627 | 2005 |
| Management of Crohn's disease in adults GR Lichtenstein, SB Hanauer, WJ Sandborn, ... Official journal of the American College of Gastroenterology| ACG 104 (2 …, 2009 | 1247 | 2009 |
| ACG clinical guideline: management of Crohn's disease in adults GR Lichtenstein, EV Loftus, KL Isaacs, MD Regueiro, LB Gerson, ... Official journal of the American College of Gastroenterology| ACG 113 (4 …, 2018 | 1215 | 2018 |
| Comparison of scheduled and episodic treatment strategies of infliximab in Crohn’s disease P Rutgeerts, BG Feagan, GR Lichtenstein, LF Mayer, S Schreiber, ... Gastroenterology 126 (2), 402-413, 2004 | 1203 | 2004 |
| Serious infections and mortality in association with therapies for Crohn’s disease: TREAT registry GR Lichtenstein, BG Feagan, RD Cohen, BA Salzberg, RH Diamond, ... Clinical Gastroenterology and Hepatology 4 (5), 621-630, 2006 | 1113 | 2006 |
| Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis JF Colombel, P Rutgeerts, W Reinisch, D Esser, Y Wang, Y Lang, ... Gastroenterology 141 (4), 1194-1201, 2011 | 1011 | 2011 |
| Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis JD Lewis, S Chuai, L Nessel, GR Lichtenstein, FN Aberra, JH Ellenberg Inflammatory bowel diseases 14 (12), 1660-1666, 2008 | 895 | 2008 |
| Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT™ registry GR Lichtenstein, BG Feagan, RD Cohen, BA Salzberg, RH Diamond, ... Official journal of the American College of Gastroenterology| ACG 107 (9 …, 2012 | 836 | 2012 |
| Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn’s disease GR Lichtenstein, S Yan, M Bala, M Blank, BE Sands Gastroenterology 128 (4), 862-869, 2005 | 721 | 2005 |
| Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease P Rutgeerts, RH Diamond, M Bala, A Olson, GR Lichtenstein, W Bao, ... Gastrointestinal endoscopy 63 (3), 433-442, 2006 | 697 | 2006 |
| Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS) SPL Travis, D Schnell, P Krzeski, MT Abreu, DG Altman, JF Colombel, ... Gut 61 (4), 535-542, 2012 | 660 | 2012 |
| American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease GR Lichtenstein, MT Abreu, R Cohen, W Tremaine Gastroenterology 130 (3), 940-987, 2006 | 600 | 2006 |
| Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab WJ Sandborn, P Rutgeerts, BG Feagan, W Reinisch, A Olson, J Johanns, ... Gastroenterology 137 (4), 1250-1260, 2009 | 590 | 2009 |
| Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis JA Katz, C Antoni, GF Keenan, DE Smith, SJ Jacobs, GR Lichtenstein Official journal of the American College of Gastroenterology| ACG 99 (12 …, 2004 | 574 | 2004 |
| A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease DS Kotlyar, MT Osterman, RH Diamond, D Porter, WC Blonski, M Wasik, ... Clinical Gastroenterology and Hepatology 9 (1), 36-41. e1, 2011 | 528 | 2011 |
| ACG clinical guideline: preventive care in inflammatory bowel disease FA Farraye, GY Melmed, GR Lichtenstein, SV Kane Official journal of the American College of Gastroenterology| ACG 112 (2 …, 2017 | 485 | 2017 |
| Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis MT Osterman, R Kundu, GR Lichtenstein, JD Lewis Gastroenterology 130 (4), 1047-1053, 2006 | 465 | 2006 |
| Reliability and initial validation of the ulcerative colitis endoscopic index of severity SPL Travis, D Schnell, P Krzeski, MT Abreu, DG Altman, JF Colombel, ... Gastroenterology 145 (5), 987-995, 2013 | 448 | 2013 |
| Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients FN Aberra, JD Lewis, D Hass, JL Rombeau, B Osborne, GR Lichtenstein Gastroenterology 125 (2), 320-327, 2003 | 423 | 2003 |
William SandbornUniversity of California San DiegoVerified email at ucsd.edu
